en · de · es · fr · pt
cardarine-notes.peptides9000.com › Wiki › Background And Regulatory History — Evidence Review

Background And Regulatory History — Evidence Review

By Editorial Desk · published 2025-07-29 · last reviewed 2025-08-18 · Wiki

This is a working overview of GW501516, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-08-18. Anything still debated is marked as such rather than presented as settled.

Background and Regulatory History

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Regulatory Status and Detection Context

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.

Cardarine at a glance

PropertyValueNotes
Common nameCardarineCommon internet and media name.
Research codeGW501516Also written GW-1516.
Drug classPPARδ agonistNot a selective androgen receptor modulator.
Development statusDiscontinuedClinical development halted after rodent cancer findings.
Regulatory statusProhibited in sportListed by WADA; not approved as medicine.

Background and Regulatory Status

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Related pages on this site

Identity and Pharmacological Mechanism

Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Supporting material

== Structure and bonding == Most organomercury compounds feature diamagnetic Hg(II) and adopt a linear C−Hg−X structure. Indeed, no organic derivatives of Hg2+2 are known, as Hg2+2 requires electronegative substituents for condensed-phase stability. Hg(II) derivatives are neither Lewis basic or Lewis acidic. They are stable to oxygen and water, indicating the low polarity of the Hg−C bond. The structure of "mercurocene" is instructive. When made in the 1950s, it was too sensitive for structural determination. Later analysis determined that the products have the mercury σ-bonded to just one carbon of each ring, rather than a metallocene with the metal bonded to the rings' π systems.

=== 17 May === Russia claimed to have destroyed more than 100 air and naval drones over its western regions and in the Black Sea. Explosions were reported at petroleum facilities in Novorossiysk, while two people were reported killed in a drone strike in Belgorod Oblast. The Russian-installed Governor of Sevastopol, Mikhail Razvozhayev, said that the attack caused power outages in the city. Four people were killed and 31 were wounded in a Russian airstrike in Kharkiv. Two people were killed in a separate attack in Vovchansk, while one person was killed in Lyptsi. Police accused Russian soldiers in the town of using up to 40 civilian prisoners as human shields. The regional prosecutor's office also began a criminal proceeding on Russian soldiers allegedly executing a person in a wheelchair. Zelenskyy signed a bill into law permitting individuals convicted of minor offenses to serve in the Ukrainian military, as well as another bill that increases fines for draft dodgers fivefold. Zelenskyy reported the situation in Kharkiv had been "controlled" but not "stabilized". He also reported Ukraine has "about 25 percent" of the air defences needed to counter future Russian attacks, needing 120 to 130 F-16s or other advanced aircraft to achieve air "parity" with Russia.

Screening tests are offered to the asymptomatic people to reveal possible diseases. On the contrary, diagnostic tests are used to prove or disapprove certain conditions. To follow the course of the disease or the reaction to treatment, monitoring tests are presented. Lastly, there are tests during the follow-up to determine the results following treatment. The following is an example of a typical breakdown of the responsibilities of each area:

Sources: en.wikipedia.org

Supporting material

In 1953, Major General [then Brigadier General] Kim Chum Kon, Republic of Korea Army, was made an Officer of the Legion for service 25 October 1952 – 14 February 1953. For service 10 September 1952 – 27 April 1954, Brigadier General Shim On Bong of the Republic of Korea Army For service August 1953 – March 1955, Major General Chang Kuk Chang of the Republic of Korea Army In 1957, Colonel Stig Wennerström was made an Officer of the Legion for serving as an air attaché in Washington, D.C. from 1952 to 1957. In 1958, Captain S. M. Ahsan was made an Officer of the Legion for performance of outstanding services as Naval Attache to the Embassy of Pakistan, Washington, D.C. from August 1955 to July 1956. In 1959, Major General Mian Ghulam Jilani was made an Officer of the Legion for exceptionally meritorious conduct in the performance of outstanding services to the Government of the United States, from October 1952 to June 1955. In 1960 Major General Mian Hayaud Din was made an Officer of the Legion for his role as Chief of the Pakistan Military Mission to the United States from 1955 to 1960.

Earthworms feed on the decaying matter in the soil and analyzing the microbial contents of their digestive tracts (the earthworm microbiome) gives insight into the overall condition of the soil. The earthworm gut bioaccumulates heavy metals and persistent organic pollutants, causing major health problems, but its microbiome promotes the degradation of many organic pollutants. The population size of earthworms indicates soil quality, as healthy soil would contain a larger number and biomass of earthworms, in particular endogeic and anecic species.

A chainsaw (or chain saw) is a portable handheld power saw that cuts with a set of teeth attached to a rotating chain driven along a guide bar. Modern chainsaws are typically gasoline or electric and are used in activities such as tree felling, limbing, bucking, pruning, cutting firebreaks in wildland fire suppression, harvesting of firewood, for use in chainsaw art and chainsaw mills, for cutting concrete, and cutting ice. Precursors to modern chainsaws were first used in surgery, with patents for wood chainsaws beginning in the late 19th century. A chainsaw comprises an engine, a drive mechanism, a guide bar, a cutting chain, a tensioning mechanism, and safety features. Various safety practices and working techniques are used with chainsaws.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Why did clinical development stop?

Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.

Is cardarine approved for medical use?

No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.

Is cardarine approved for any medical use?

No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.

Network